Strain Data Sheet

RBRC00193

Strain Information

Image
BRC No.RBRC00193
TypeTargeted MutationCartagena
SpeciesMus musculus
Strain nameGRS.Cg-Tnc<tm1Sia>/Rbrc
Former Common nameGRS/A-TgH(Tnc), GR-TNKO
H-2 Haplotype
ES Cell lineTT2 [(C57BL/6NCrlj x CBA/JNCrlj)F1]
Background strainGRS/A
Appearancealbino [a/a, c/c]
Strain developmentThe original tenascin deficient mice with mixed genetic background was reported to develop normally without tenascin. To clarify the biological function of tenascin-C in vivo, several congenic strains with inbred background have been developed by Dr. Kusakabe M, Cell Biology Laboratory, Life Science Tsukuba Research Center, RIKEN since 1992.The tenascin-deficient congenic strains were thus developed by successive backcrossing into A, BALB/cA, C57BL/6N, C3H/HeN, and GRS/A.
Strain descriptionThis strain is useful to study the biological function of extracellular matrix tenascin-C in vivo, espacially in the field of tumor development, tumor metastasis, wound healing, tissue regeneration, angiogenesis, tissue interaction etc. Background strain, GRS/A have a high incidence of mammary tumours which are highly hormone-responsive in breeding females.
Colony maintenance
References
Tyrosine hydroxylase activity and its mRNA level in dopaminergic neurons of tenascin gene knockout mouse.
Fukamauchi F, Mataga N, Wang Y J, Sato S, Yoshiki A, Kusakabe M
Biochem. Biophys. Res. Commun., 231, 356-359 (1997). 9070278

Murine tenascin: cDNA cloning, structure and temporal expression of isoforms.
Saga Y, Tsukamoto T, Jing N, Kusakabe M, Sakakura T
Gene, 104, 177-185 (1991). 1717349

Abnormal behavior and neurotransmissions of tenascin gene knockout mouse.
Fukamauchi F, Mataga N, Wang Y J, Sato S, Youshiki A, Kusakabe M
Biochem. Biophys. Res. Commun., 221, 151-156 (1996). 8660327

Tenascin-C promotes healing of Habu-snake venom-induced glomerulonephritis: studies in knockout congenic mice and in culture.
Nakao N, Hiraiwa N, Yoshiki A, Ike F, Kusakabe M
Am. J. Pathol., 152, 1237-1245 (1998). 9588892

Loss of cortical and thalamic neuronal tenascin-C expression in a transgenic mouse expressing exon 1 of the human Huntington disease gene.
Kusakabe M, Mangiarini L, Laywell E D, Bates G P, Yoshiki A, Hiraiwa N, Inoue J, Steindler D A
J. Comp. Neurol., 430, 485-500 (2001). 11169482

Can tenascin be redundant in cancer development?
Sakakura T, Kusakabe M
Perspect. Dev. Neurobiol., 2, 111-116 (1994). 7530137

Tenascin-C expression and splice variant in habu snake venom-induced glomerulonephritis.
Matsumoto K, Hiraiwa N, Yoshiki A, Ohnishi M, Kusakabe M
Exp. Mol. Pathol., 72, 186-195 (2002). 12009782

Effect of tenascin-C deficiency on chemically induced dermatitis in the mouse.
Koyama Y, Kusubata M, Yoshiki A, Hiraiwa N, Ohashi T, Irie S, Kusakabe M
J. Invest. Dermatol., 111, 930-935 (1998). 9856798

PDGF receptor-alpha deficiency in glomerular mesangial cells of tenascin-C knockout mice.
Matsumoto K, Hiraiwa N, Yoshiki A, Ohnishi M, Kusakabe M
Biochem. Biophys. Res. Commun., 290, 1220-1227 (2002). 11811993

Tenascin knockout mice: barrels, boundary molecules, and glial scars.
Steindler D A, Settles D, Erickson H P, Laywell E D, Yoshiki A, Faissner A, Kusakabe M
J. Neurosci., 15, 1971-1983 (1995). 7534342
more 2 references
Mice develop normally without tenascin.
Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S
Genes Dev., 6, 1821-1831 (1992). 1383086

Corneal wound healing in tenascin knockout mouse.
Matsuda A, Yoshiki A, Tagawa Y, Matsuda H, Kusakabe M
Invest. Ophthalmol. Visual. Sci., 40, 1071-1080 (1999). 10235540

Health Report

Examination Date / Room / Rack

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NameCommon NamesPromoterDiseases Related to This Gene
Tnctenascin C4Tnctargeted mutation 1, Shinichi Aizawa
  • autosomal dominant nonsyndromic hearing loss 56(MedGEN)
    • lacZbeta-galactosidase (E. coli)4
  • autosomal dominant nonsyndromic hearing loss 56(MedGEN)
    • neoneomycin resistance gene (E. coli)4mouse phosphoglycerate kinase promoter (PGK promoter)
  • autosomal dominant nonsyndromic hearing loss 56(MedGEN)

    • Phenotype

    Annotation by Mammalian phenotyhpe ontology
  • abnormal CNS synaptic transmission(MP:0002206)

  • abnormal circadian behavior(MP:0020467)

  • abnormal serotonin level(MP:0005322)

  • decreased dopamine level(MP:0005643)

  • hyperactivity(MP:0001399)
    • more 3 phenotypes
  • impaired swimming(MP:0001522)

  • increased stereotypic behavior(MP:0001409)

  • no abnormal phenotype detected(MP:0002169)
    • Detailed phenotype data

    Ordering Information

    Donor DNAE. coli lacZ, mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse tenascin genomic DNA
    Research application
    Specific Term and ConditionsIn publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Am. J. Pathol., 152, 1237-1245 (1998). J. Invest. Dermatol., 111, 930-935 (1998). Invest. Ophthalmol. Visual. Sci., 40, 1071-1080 (1999).
    DepositorRIKEN BRC (RIKEN BRC)
    Strain Statusan icon for Frozen embryosFrozen embryos
    Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
    Additional Info.Necessary documents for ordering:
    1. Order form (Japanese / English)
    2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    3. Acceptance of responsibility for living modified organism (Japanese / English)

    Genotyping protocol -PCR-

    BRC mice in Publications

    No Data